Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.

Saved in:
Bibliographic Details
Title: Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Authors: Terui T; Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi, Tokyo, 173-8610, Japan. terui.tadashi@nihon-u.ac.jp., Okubo Y; Tokyo Medical University, Tokyo, Japan., Kobayashi S; Seibo International Catholic Hospital, Tokyo, Japan., Sano S; Kochi Medical School, Kochi University, Kochi, Japan., Morita A; Nagoya City University, Nagoya, Japan., Imafuku S; Fukuoka University, Fukuoka, Japan., Tada Y; Teikyo University, Tokyo, Japan., Abe M; Sapporo Skin Clinic, Sapporo, Japan., Yaguchi M; Amgen K.K., Tokyo, Japan., Uehara N; Amgen K.K., Tokyo, Japan., Handa T; Amgen K.K., Tokyo, Japan., Tanaka M; Amgen K.K., Tokyo, Japan., Zhang W; Amgen Inc., Thousand Oaks, CA, USA., Paris M; Amgen Inc., Thousand Oaks, CA, USA., Murakami M; Ehime University Graduate School of Medicine, Ehime, Japan.
Source: American journal of clinical dermatology [Am J Clin Dermatol] 2024 Jan; Vol. 25 (1), pp. 165-167.
Publication Type: Published Erratum
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1888
DOI:10.1007/s40257-023-00825-0